De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability
- PMID: 26079862
- PMCID: PMC4744742
- DOI: 10.1002/ajmg.a.37189
De novo, heterozygous, loss-of-function mutations in SYNGAP1 cause a syndromic form of intellectual disability
Abstract
De novo mutations (DNM) in SYNGAP1, encoding Ras/Rap GTPase-activating protein SynGAP, have been reported in individuals with nonsyndromic intellectual disability (ID). We identified 10 previously unreported individuals with SYNGAP1 DNM; seven via the Deciphering Developmental Disorders (DDD) Study, one through clinical analysis for copy number variation and the remaining two (monozygotic twins) via a research multi-gene panel analysis. Seven of the nine heterozygous mutations are likely to result in loss-of-function (3 nonsense; 3 frameshift; 1 whole gene deletion). The remaining two mutations, one of which affected the monozygotic twins, were missense variants. Each individual carrying a DNM in SYNGAP1 had moderate-to-severe ID and 7/10 had epilepsy; typically myoclonic seizures, absences or drop attacks. 8/10 had hypotonia, 5/10 had significant constipation, 7/10 had wide-based/unsteady gait, 3/10 had strabismus, and 2/10 had significant hip dysplasia. A proportion of the affected individuals had a similar, myopathic facial appearance, with broad nasal bridge, relatively long nose and full lower lip vermilion. A distinctive behavioral phenotype was also observed with aggressive/challenging behavior and significant sleep problems being common. 7/10 individuals had MR imaging of the brain each of which was reported as normal. The clinical features of the individuals reported here show significant overlap with those associated with 6p21.3 microdeletions, confirming that haploinsufficiency for SYNGAP1 is responsible for both disorders. © 2015 Wiley Periodicals, Inc.
Keywords: 6p21.3 microdeletion; DDD study; SYNGAP1; behavioral phenotype; epilepsy; hip dysplasia; hypertrichosis; intellectual disability; strabismus; syndrome.
© 2015 Wiley Periodicals, Inc.
Figures
Similar articles
-
Analysis of 31-year-old patient with SYNGAP1 gene defect points to importance of variants in broader splice regions and reveals developmental trajectory of SYNGAP1-associated phenotype: case report.BMC Med Genet. 2017 Jun 2;18(1):62. doi: 10.1186/s12881-017-0425-4. BMC Med Genet. 2017. PMID: 28576131 Free PMC article.
-
Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency.Hum Mutat. 2013 Feb;34(2):385-94. doi: 10.1002/humu.22248. Epub 2012 Dec 12. Hum Mutat. 2013. PMID: 23161826
-
Novel SYNGAP1 variant in a patient with intellectual disability and distinctive dysmorphisms.Congenit Anom (Kyoto). 2018 Nov;58(6):188-190. doi: 10.1111/cga.12273. Epub 2018 Feb 13. Congenit Anom (Kyoto). 2018. PMID: 29381230 Review.
-
Disruption of PHF21A causes syndromic intellectual disability with craniofacial anomalies, epilepsy, hypotonia, and neurobehavioral problems including autism.Mol Autism. 2019 Oct 22;10:35. doi: 10.1186/s13229-019-0286-0. eCollection 2019. Mol Autism. 2019. PMID: 31649809 Free PMC article.
-
[Autosomal dominant mental retardation type 5 caused by SYNGAP1 gene mutations: a report of 8 cases and literature review].Zhongguo Dang Dai Er Ke Za Zhi. 2023 May 15;25(5):489-496. doi: 10.7499/j.issn.1008-8830.2301054. Zhongguo Dang Dai Er Ke Za Zhi. 2023. PMID: 37272175 Free PMC article. Review. Chinese.
Cited by
-
Re-expression of SynGAP protein in adulthood improves translatable measures of brain function and behavior.Elife. 2019 Apr 26;8:e46752. doi: 10.7554/eLife.46752. Elife. 2019. PMID: 31025938 Free PMC article.
-
CNS critical periods: implications for dystonia and other neurodevelopmental disorders.JCI Insight. 2021 Feb 22;6(4):e142483. doi: 10.1172/jci.insight.142483. JCI Insight. 2021. PMID: 33616084 Free PMC article. Review.
-
Dysfunction of the corticostriatal pathway in autism spectrum disorders.J Neurosci Res. 2020 Nov;98(11):2130-2147. doi: 10.1002/jnr.24560. Epub 2019 Nov 22. J Neurosci Res. 2020. PMID: 31758607 Free PMC article. Review.
-
Phenotypic characterization of individuals with SYNGAP1 pathogenic variants reveals a potential correlation between posterior dominant rhythm and developmental progression.J Neurodev Disord. 2019 Aug 8;11(1):18. doi: 10.1186/s11689-019-9276-y. J Neurodev Disord. 2019. PMID: 31395010 Free PMC article.
-
Understanding intellectual disability and autism spectrum disorders from common mouse models: synapses to behaviour.Open Biol. 2019 Jun 28;9(6):180265. doi: 10.1098/rsob.180265. Epub 2019 Jun 12. Open Biol. 2019. PMID: 31185809 Free PMC article. Review.
References
-
- Berryer MH, Hamdan FF, Klitten LL, Moller RS, Carmant L, Schwartzentruber J, Patry L, Dobrzeniecka S, Rochefort D, Neugnot‐Cerioli M, Lacaille JC, Niu Z, Eng CM, Yang Y, Palardy S, Belhumeur C, Rouleau GA, Tommerup N, Immken L, Beauchamp MH, Patel GS, Majewski J, Tarnopolsky MA, Scheffzek K, Hjalgrim H, Michaud JL, Di Cristo G. 2013. Mutations in SYNGAP1 cause intellectual disability, autism, and a specific form of epilepsy by inducing haploinsufficiency. Hum Mutat 34:385–394. - PubMed
-
- Carvill GL, Heavin SB, Yendle SC, McMahon JM, O'Roak BJ, Cook J, Khan A, Dorschner MO, Weaver M, Calvert S, Malone S, Wallace G, Stanley T, Bye AM, Bleasel A, Howell KB, Kivity S, Mackay MT, Rodriguez‐Casero V, Webster R, Korczyn A, Afawi Z, Zelnick N, Lerman‐Sagie T, Lev D, Moller RS, Gill D, Andrade DM, Freeman JL, Sadleir LG, Shendure J, Berkovic SF, Scheffer IE, Mefford HC. 2013. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat Genet 45:825–830. - PMC - PubMed
-
- Cook EHJ. 2011. De novo autosomal dominant mutation in SYNGAP1. Autism Res 4:155–156. - PubMed
-
- de Ligt J, Willemsen MH, van Bon BW, Kleefstra T, Yntema HG, Kroes T, Vulto‐van Silfhout AT, Koolen DA, de Vries P, Gilissen C, del Rosario M, Hoischen A, Scheffer H, de Vries BB, Brunner HG, Veltman JA, Vissers LE. 2012. Diagnostic exome sequencing in persons with severe intellectual disability. N Engl J Med 367:1921–1929. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
